Trial intelligence / Profile preview

Effect of betahistine on body weight in obese female subjects

2008-001840-38Phase 2Completed

Sponsor
Obecure Ltd.
Start
Jun 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in obesity comparing betahistine with placebo (2 arms). Primary endpoint: Primary: change in body weight at 12 weeks. Started Jun 2008; status: completed.

02

Drugs

betahistine
03

Conditions

obesity

Beyond the preview

Go deeper on 2008-001840-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-001840-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call